|
TW574214B
(en)
|
1994-06-08 |
2004-02-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
AU3176297A
(en)
|
1996-06-25 |
1998-01-14 |
Novartis Ag |
Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
|
|
US5985848A
(en)
|
1997-10-14 |
1999-11-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of nucleoside metabolism
|
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
CZ20022353A3
(cs)
|
2000-01-07 |
2003-02-12 |
Universitaire Instelling Antwerpen |
Deriváty purinu, způsob jejich přípravy a jejich použití
|
|
RU2269523C2
(ru)
|
2000-04-28 |
2006-02-10 |
Акадиа Фармасьютикалз, Инк. |
Мускариновые агонисты
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
WO2003016254A1
(en)
*
|
2001-08-09 |
2003-02-27 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
|
|
TW200301251A
(en)
|
2001-12-20 |
2003-07-01 |
Wyeth Corp |
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
|
|
RU2217159C1
(ru)
*
|
2002-03-18 |
2003-11-27 |
ООО "Содарм фарма" |
Раствор для ингаляций фармацевтической композиции глутовент и способ его терапевтического применения
|
|
DE60237425D1
(de)
|
2002-03-28 |
2010-10-07 |
Univerzita Palackeho V Olomouc |
PyrazoloÄ4,3-dÜpyrimidine, Verfahren zu ihrer Herstellung und therapeutische Anwendung
|
|
US20040063658A1
(en)
|
2002-05-06 |
2004-04-01 |
Roberts Christopher Don |
Nucleoside derivatives for treating hepatitis C virus infection
|
|
US6713241B2
(en)
|
2002-08-09 |
2004-03-30 |
Eastman Kodak Company |
Thermally developable emulsions and imaging materials containing binder mixture
|
|
KR101081226B1
(ko)
|
2002-08-21 |
2011-11-07 |
인더스트리얼 리서치 리미티드 |
뉴클레오시드 포스포릴라제 및 뉴클레오시다제의 억제제
|
|
MXPA05003193A
(es)
|
2002-09-27 |
2005-06-08 |
Sumitomo Pharma |
Compuesto de adenina novedoso y uso del mismo.
|
|
US20060148805A1
(en)
|
2003-07-01 |
2006-07-06 |
Meng Hsin Chen |
Opthalmic compositions for treating ocular hypertension
|
|
WO2005020892A2
(en)
|
2003-08-08 |
2005-03-10 |
Mitochroma Research, Inc. |
Pharmaceutical compositions and methods for metabolic modulation
|
|
EA200600540A1
(ru)
|
2003-09-05 |
2006-08-25 |
Анадис Фармасьютикалз, Инк. |
Введение лигандов tlr7 и их пролекарств для лечения инфекции вируса гепатита с
|
|
EP1696912B1
(en)
|
2003-10-03 |
2016-05-11 |
3M Innovative Properties Company |
Pyrazolopyridines and analogs thereof
|
|
PL1699512T3
(pl)
|
2003-11-03 |
2012-11-30 |
Glaxo Group Ltd |
Urządzenie do dozowania płynów
|
|
UA86798C2
(en)
|
2004-03-26 |
2009-05-25 |
ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. |
9-substituted 8-oxoadenine compound
|
|
JPWO2005092892A1
(ja)
|
2004-03-26 |
2008-02-14 |
大日本住友製薬株式会社 |
８−オキソアデニン化合物
|
|
AR048518A1
(es)
|
2004-04-02 |
2006-05-03 |
Osi Pharm Inc |
Inhibidores heterobiciclicos de proteina quinasas sustituidos con anillos 6,6 -biciclicos
|
|
EP1753428A4
(en)
|
2004-05-14 |
2010-09-15 |
Abbott Lab |
INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
|
|
US20060029642A1
(en)
|
2004-08-03 |
2006-02-09 |
Dusan Miljkovic |
Methods and compositions for improved chromium complexes
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
BRPI0611435A2
(pt)
|
2005-05-04 |
2010-09-08 |
Pfizer Ltd |
derivados de 2-amido-6-amino-8-oxopurina, composições farmacêuticas, uso e processo de preparo dos mesmos
|
|
NZ540160A
(en)
|
2005-05-20 |
2008-03-28 |
Einstein Coll Med |
Inhibitors of nucleoside phosphorylases
|
|
EP1915377A1
(en)
|
2005-07-22 |
2008-04-30 |
Sunesis Pharmaceuticals, Inc. |
Pyrazolo pyrimidines useful as aurora kinase inhibitors
|
|
CN101304748A
(zh)
|
2005-08-22 |
2008-11-12 |
加利福尼亚大学董事会 |
Tlr激动剂
|
|
US8003624B2
(en)
|
2005-08-25 |
2011-08-23 |
Schering Corporation |
Functionally selective ALPHA2C adrenoreceptor agonists
|
|
PE20070336A1
(es)
|
2005-08-25 |
2007-04-16 |
Schering Corp |
Compuestos de indolina como agonistas de receptores adrenergicos alfa2c funcionalmente selectivos
|
|
JP4584335B2
(ja)
|
2005-09-02 |
2010-11-17 |
ファイザー・インク |
ヒドロキシ置換１ｈ−イミダゾピリジンおよび方法
|
|
TW200801003A
(en)
|
2005-09-16 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
|
US20080269240A1
(en)
|
2005-09-22 |
2008-10-30 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel Adenine Compound
|
|
WO2007034817A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
|
WO2007034881A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
|
US20090105212A1
(en)
|
2005-09-22 |
2009-04-23 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel adenine compound
|
|
TW200745114A
(en)
|
2005-09-22 |
2007-12-16 |
Astrazeneca Ab |
Novel compounds
|
|
US20090099216A1
(en)
|
2005-09-22 |
2009-04-16 |
Astrazeneca Aktiebolag A Corporation Of Sweden |
Novel adenine compound
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
EP1987030B1
(en)
|
2006-02-17 |
2011-11-09 |
Pfizer Limited |
3 -deazapurine derivatives as tlr7 modulators
|
|
CA2680789C
(en)
|
2006-03-28 |
2016-02-16 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
GB0610666D0
(en)
|
2006-05-30 |
2006-07-05 |
Glaxo Group Ltd |
Fluid dispenser
|
|
EP2029597A4
(en)
|
2006-05-31 |
2011-11-23 |
Univ California |
purine analogs
|
|
US8138172B2
(en)
|
2006-07-05 |
2012-03-20 |
Astrazeneca Ab |
8-oxoadenine derivatives acting as modulators of TLR7
|
|
WO2008005555A1
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
|
TW200831105A
(en)
|
2006-12-14 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
|
TW200843779A
(en)
|
2007-02-19 |
2008-11-16 |
Smithkline Beecham Corp |
Compounds
|
|
DK2132209T3
(da)
|
2007-03-19 |
2014-04-14 |
Astrazeneca Ab |
9-substituerede 8-oxo-adeninforbindelser som modulatorer af tlr7 (toll-like receptor 7)
|
|
US8063051B2
(en)
|
2007-03-19 |
2011-11-22 |
Astrazeneca Ab |
9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators
|
|
AR065784A1
(es)
|
2007-03-20 |
2009-07-01 |
Dainippon Sumitomo Pharma Co |
Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
|
|
EP2138497A4
(en)
|
2007-03-20 |
2012-01-04 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
CA2691444C
(en)
|
2007-06-29 |
2016-06-14 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
EP2187883A2
(en)
|
2007-08-10 |
2010-05-26 |
Genelabs Technologies, Inc. |
Nitrogen containing bicyclic chemical entities for treating viral infections
|
|
PE20091156A1
(es)
|
2007-12-17 |
2009-09-03 |
Astrazeneca Ab |
Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
|
|
WO2009151910A2
(en)
|
2008-05-25 |
2009-12-17 |
Wyeth |
Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
|
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
|
KR101649881B1
(ko)
|
2008-08-11 |
2016-08-30 |
글락소스미스클라인 엘엘씨 |
신규의 아데닌 유도체
|
|
MX2011001662A
(es)
|
2008-08-11 |
2011-03-24 |
Glaxosmithkline Llc |
Derivados de purina para usarse en el tratamiento de enfermedades alergicas, inflamatorias e infecciosas.
|
|
US8575181B2
(en)
|
2008-08-11 |
2013-11-05 |
Glaxosmithkline Llc |
Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
|
|
US8802684B2
(en)
|
2008-08-11 |
2014-08-12 |
Glaxosmithkline Llc |
Adenine derivatives
|
|
WO2010018132A1
(en)
|
2008-08-11 |
2010-02-18 |
Smithkline Beecham Corporation |
Compounds
|
|
WO2010083725A1
(zh)
|
2009-01-20 |
2010-07-29 |
山东轩竹医药科技有限公司 |
含有取代的含氮稠杂环的头孢菌素衍生物
|
|
WO2010111406A2
(en)
*
|
2009-03-24 |
2010-09-30 |
Myriad Pharmaceuticals, Inc. |
Compounds and therapeutic uses thereof
|
|
AU2010279299B2
(en)
|
2009-08-07 |
2015-10-01 |
Glaxosmithkline Biologicals Sa |
Lipidated oxoadenine derivatives
|
|
EA021048B1
(ru)
|
2010-02-10 |
2015-03-31 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Малеат 6-амино-2-{[(1s)-1-метилбутил]окси}-9-[5-(1-пиперидинил)пентил]-7,9-дигидро-8н-пурин-8-она
|
|
WO2011098451A1
(en)
|
2010-02-10 |
2011-08-18 |
Glaxosmithkline Llc |
Purine derivatives and their pharmaceutical uses
|
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
|
WO2012092552A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
WO2012106343A2
(en)
|
2011-02-01 |
2012-08-09 |
The Board Of Trustees Of The University Of Illinois |
Hdac inhibitors and therapeutic methods using the same
|
|
JP5813785B2
(ja)
|
2011-02-04 |
2015-11-17 |
デュケイン ユニバーシティー オブ ザ ホリー スピリット |
抗チューブリン活性を有する二環式および三環式のピリミジンチロシンキナーゼ阻害剤ならびに患者の処置方法
|
|
AU2012289042A1
(en)
|
2011-07-22 |
2014-03-13 |
Glaxosmithkline Llc |
Composition
|
|
UA114109C2
(xx)
|
2012-08-24 |
2017-04-25 |
|
Піразолопіримідинові сполуки
|
|
ES2625023T3
(es)
|
2012-11-20 |
2017-07-18 |
Glaxosmithkline Llc |
Compuestos novedosos
|
|
US9540383B2
(en)
|
2012-11-20 |
2017-01-10 |
Glaxosmithkline Llc |
Pyrrolopyrimidines as therapeutic agents for the treatment of diseases
|
|
US9550785B2
(en)
|
2012-11-20 |
2017-01-24 |
Glaxosmithkline Llc |
Pyrrolopyrimidines as therapeutic agents for the treatment of diseases
|
|
CA2938476A1
(en)
|
2014-02-20 |
2015-08-27 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pyrrolo[3,2-d]pyrimidine derivatives as inducers of human interferon
|